S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
The Safest Option in Trades! (Ad)pixel
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
The Safest Option in Trades! (Ad)pixel
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
UK train strikes and energy hikes add to a week of turmoil
The Safest Option in Trades! (Ad)pixel
Russia blindfolds, detains Ukraine nuclear plant chief
NIH to fund unproven ALS drugs under patient-backed law
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
The Safest Option in Trades! (Ad)pixel
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
The Safest Option in Trades! (Ad)pixel
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
UK train strikes and energy hikes add to a week of turmoil
The Safest Option in Trades! (Ad)pixel
Russia blindfolds, detains Ukraine nuclear plant chief
NIH to fund unproven ALS drugs under patient-backed law
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
The Safest Option in Trades! (Ad)pixel
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
The Safest Option in Trades! (Ad)pixel
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
UK train strikes and energy hikes add to a week of turmoil
The Safest Option in Trades! (Ad)pixel
Russia blindfolds, detains Ukraine nuclear plant chief
NIH to fund unproven ALS drugs under patient-backed law
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
The Safest Option in Trades! (Ad)pixel
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
The Safest Option in Trades! (Ad)pixel
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
UK train strikes and energy hikes add to a week of turmoil
The Safest Option in Trades! (Ad)pixel
Russia blindfolds, detains Ukraine nuclear plant chief
NIH to fund unproven ALS drugs under patient-backed law
TSE:CRON

Cronos Group - CRON Stock Forecast, Price & News

C$3.87
-0.15 (-3.73%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
C$3.87
C$4.02
50-Day Range
C$3.77
C$4.60
52-Week Range
C$3.32
C$8.45
Volume
142,965 shs
Average Volume
346,537 shs
Market Capitalization
C$1.46 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$5.31
CRON stock logo

About Cronos Group (TSE:CRON) Stock

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Stock News Headlines

CRON Cronos Group Inc.
Turn a New Leaf With These Hot Tobacco Dividend Stocks
Cronos Group Inc stock raised on Friday.
Here's Why Cronos Is Soaring Today
Altria: Stop Caring About Juul
TSX Remains Negative as Weekly Figure Drops
Equities Still Green by Noon
See More Headlines
Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
626
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$5.13
High Stock Price Forecast
C$10.00
Low Stock Price Forecast
C$3.00
Forecasted Upside/Downside
+37.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.57
Research Coverage
6 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$94.30 million
Cash Flow
C$2.49 per share
Book Value
C$3.41 per share

Miscellaneous

Free Float
N/A
Market Cap
C$1.46 billion
Optionable
Optionable
Beta
N/A

Key Executives

  • Mr. Michael Ryan Gorenstein J.D. (Age 35)
    Pres, CEO & Chairman
    Comp: $389.15k
  • Mr. Robert L. Madore (Age 57)
    Chief Financial Officer
    Comp: $164.42k
  • Ms. Shannon Buggy (Age 52)
    Sr. VP & Global Head of People
    Comp: $438.81k
  • Ms. Anna Shlimak (Age 36)
    Sr. VP of Corp. Affairs & Strategy
    Comp: $422.03k
  • Mr. Carlos Cortez (Age 49)
    VP, Controller & Principal Accounting Officer
  • Mr. Shayne J. Laidlaw
    Director of Investor Relations & Strategy
  • Mr. Terry Gregory-Joseph Doucet (Age 32)
    Sr. VP of Legal & Regulatory Affairs and Corp. Sec.
  • Mr. Jeffrey David Jacobson (Age 36)
    Sr. VP & Head of Growth of North America
  • Mr. Arye Weigensberg
    Head of R&D
  • Mr. John Griese (Age 60)
    Sr. VP & Head of Operations of North America













CRON Stock - Frequently Asked Questions

Should I buy or sell Cronos Group stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CRON shares.
View CRON analyst ratings
or view top-rated stocks.

What is Cronos Group's stock price forecast for 2022?

6 analysts have issued 1 year target prices for Cronos Group's shares. Their CRON share price forecasts range from C$3.00 to C$10.00. On average, they predict the company's stock price to reach C$5.13 in the next year. This suggests a possible upside of 32.4% from the stock's current price.
View analysts price targets for CRON
or view top-rated stocks among Wall Street analysts.

How have CRON shares performed in 2022?

Cronos Group's stock was trading at C$4.98 at the beginning of the year. Since then, CRON stock has decreased by 22.3% and is now trading at C$3.87.
View the best growth stocks for 2022 here
.

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Aurora Cannabis (ACB), Canopy Growth (WEED), NVIDIA (NVDA), Aphria (APHA), Advanced Micro Devices (AMD), Netflix (NFLX), Walt Disney (DIS) and Intel (INTC).

What is Cronos Group's stock symbol?

Cronos Group trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRON."

How do I buy shares of Cronos Group?

Shares of CRON stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately C$3.87.

How much money does Cronos Group make?

Cronos Group (TSE:CRON) has a market capitalization of C$1.46 billion and generates C$94.30 million in revenue each year.

How many employees does Cronos Group have?

The company employs 626 workers across the globe.

How can I contact Cronos Group?

Cronos Group's mailing address is Suite 300, Toronto, Ontario M5V 2G9. The official website for the company is www.thecronosgroup.com. The company can be reached via phone at 416-504-0004.

This page (TSE:CRON) was last updated on 10/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.